Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Rank in Stocks #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$150.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Poniard Pharmaceuticals, Inc. (PARD)

Category

Stock price history for Poniard Pharmaceuticals, Inc. (PARD)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $1.69K on 1988-08-01
Stock price history of Poniard Pharmaceuticals, Inc. from 1988 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -99.00%
2022 0.00%
2021 -73.59%
2020 68.39%
2019 -58.15%
2018 0.25%
2017 -41.00%
2016 2.48%
2015 -45.77%
2014 -26.13%
2013 -32.03%
2012 -90.08%
2011 -82.25%
2010 -77.28%
2009 282.90%
2008 -55.38%
2007 -20.51%
2006 12.16%
2005 -57.29%
2004 -54.54%
2003 688.74%
2002 -88.91%
2001 -12.65%
2000 77.36%
1999 162.56%
1998 -76.29%
1997 24.18%
1996 -29.30%
1995 19.35%
1994 -39.86%
1993 -35.31%
1992 -11.37%
1991 687.42%
1990 -85.32%
1989 -41.53%
1988 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR